A biotech startup specialized in the discovery and commercialization of non-coding biomarkers, for drug discovery and precision medicine
Ciscovery Bio predicts individual responses to cytotoxicity and drugs by utilizing CRM (CisRegulatory Module) biomarker mass discovery technology. This technology is used to develop new drugs and to implement precision medical technology.